Abstract
The methodology to evaluate either a test or treatment is well developed and understood. However, the design, conduct and interpretation of a combination of a test and a treatment in a single study are fraught with complexities. There are two distinct study designs to evaluate test-treatment combinations, with randomisation occurring either before or after the test. We present critical issues that need to be considered when evaluating and appraising test-treatment combinations, using the example of research on the uterine artery Doppler test to predict, and aspirin to prevent, pre-eclampsia.
| Original language | English |
|---|---|
| Pages (from-to) | 801-808 |
| Number of pages | 8 |
| Journal | BJOG |
| Volume | 117 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 1 Jun 2010 |
Keywords
- aspirin
- pre-eclampsia
- uterine artery doppler
- test-treatment combinations
Fingerprint
Dive into the research topics of 'How to interpret randomised trials of test-treatment combinations: a critical evaluation of research on uterine Doppler test to predict, and aspirin to prevent, pre-eclampsia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver